This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Intravenous thrombolytic therapy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Four phase 3 trials of intravenous t-PA for ischaemic stroke have been reported. The FDA of North America approved this therapy on the basis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study (NINDS rt-PA Stroke Study). Other large trials have been less favourable including ECASS I, ECASS II and ATLANTIS.

Three trials of streptokinase have been initiated but halted because of excess mortality and poor outcome.


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page